Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy.

ABSTRACT:

Objective

To evaluate the outcomes 1 year and longer following stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy in a large series of patients treated over a 5-year period since introduction of this novel technique.

Methods

Surgical outcomes of a consecutive series of 58 patients with mesial temporal lobe epilepsy who underwent the surgery at our institution with at least 12 months of follow-up were retrospectively evaluated. A subgroup analysis was performed comparing patients with and without mesial temporal sclerosis.

Results

One year following stereotactic laser amygdalohippocampotomy, 53.4% (95% confidence interval [CI] = 40.8-65.7%) of all patients were free of disabling seizures (Engel I). Three of 9 patients became seizure-free follow

SUBMITTER: Gross RE 

PROVIDER: S-EPMC5877322 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature